These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy. Chapman MJ; Sposito AC Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305 [TBL] [Abstract][Full Text] [Related]
8. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders. McIntyre RS; Alsuwaidan M; Goldstein BI; Taylor VH; Schaffer A; Beaulieu S; Kemp DE; Ann Clin Psychiatry; 2012 Feb; 24(1):69-81. PubMed ID: 22303523 [TBL] [Abstract][Full Text] [Related]
9. Approach to treatment of the patient with metabolic syndrome: lifestyle therapy. Stone NJ; Saxon D Am J Cardiol; 2005 Aug; 96(4A):15E-21E. PubMed ID: 16098838 [TBL] [Abstract][Full Text] [Related]
10. Impact of obesity on cardiovascular disease. Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA Med Clin North Am; 2011 Sep; 95(5):919-37. PubMed ID: 21855700 [TBL] [Abstract][Full Text] [Related]
11. Management issues in the metabolic syndrome. Deedwania PC; Gupta R J Assoc Physicians India; 2006 Oct; 54():797-810. PubMed ID: 17214277 [TBL] [Abstract][Full Text] [Related]
12. Metabolic complications in liver transplant recipients. Jiménez-Pérez M; González-Grande R; Omonte Guzmán E; Amo Trillo V; Rodrigo López JM World J Gastroenterol; 2016 Jul; 22(28):6416-23. PubMed ID: 27605877 [TBL] [Abstract][Full Text] [Related]
13. [Metabolic syndrome as a coronary risk factor. Prevention and treatment]. Kłosiewicz-Latoszek L; Cybulska B Kardiol Pol; 2003 Jul; 59(7):59-65. PubMed ID: 14560351 [No Abstract] [Full Text] [Related]
14. The metabolic syndrome--from insulin resistance to obesity and diabetes. Gallagher EJ; Leroith D; Karnieli E Med Clin North Am; 2011 Sep; 95(5):855-73. PubMed ID: 21855696 [TBL] [Abstract][Full Text] [Related]
15. Obesity; epiphenomenon or cause of metabolic syndrome? Lois K; Young J; Kumar S Int J Clin Pract; 2008 Jun; 62(6):932-8. PubMed ID: 18479286 [TBL] [Abstract][Full Text] [Related]
16. [Metabolic Syndrome: clinical and pathophysiological basis for a rational therapeutical approach]. Martínez R G; Alonso K R; Novik A V Rev Med Chil; 2009 May; 137(5):685-94. PubMed ID: 19701560 [TBL] [Abstract][Full Text] [Related]